跳至主要内容
临床试验/EUCTR2014-003532-39-NL
EUCTR2014-003532-39-NL进行中(未招募)1 期

The effect of sitagliptin on brown adipose tissue and whole-body metabolism in overweight pre-diabetic men - SitaBAT study

eiden University Medical Center0 个研究点开始时间: 2014年10月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • - Male volunteers, 30 Caucasians, born in the Netherlands
  • - Age: 35-50 years
  • - BMI = 25 and = 30 kg/m2
  • - Plasma glucose levels 2 h after OGTT between 7.8 and 11 mM (e.g. impaired glucose tolerance)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Diabetes mellitus (determined on basis of oral glucose tolerance test (OGTT) defined by ADA criteria (22)
  • - BMI > 30 kg/m2 or < 25 kg/m2
  • - Plasma glucose levels 2 h after OGTT < 7.8 mM or > 11,1
  • - Use of medication known to influence glucose and/or lipid metabolism or BAT activity (e.g. beta blockers)
  • - Any significant chronic disease
  • - Renal, hepatic or endocrine disease
  • - Participation in an intensive weight-loss program or vigorous exercise program during the last year before the start of the study
  • - Difficulties to insert an intravenous catheter
  • - Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year

研究者

发起方
eiden University Medical Center

相似试验